Arantza Onaindía

452 total citations
11 papers, 202 citations indexed

About

Arantza Onaindía is a scholar working on Pathology and Forensic Medicine, Genetics and Dermatology. According to data from OpenAlex, Arantza Onaindía has authored 11 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 4 papers in Genetics and 4 papers in Dermatology. Recurrent topics in Arantza Onaindía's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Arantza Onaindía is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Arantza Onaindía collaborates with scholars based in Spain, United Kingdom and United States. Arantza Onaindía's co-authors include Miguel Á. Piris, L. Jeffrey Medeiros, Keyur P. Patel, Socorro Marıá Rodríguez-Pinilla, Manuela Mollejo, Santiago Montes‐Moreno, Carmen González‐Vela, M. Ara, Lucía Prieto‐Torres and Luís Requena and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Arantza Onaindía

9 papers receiving 198 citations

Peers

Arantza Onaindía
Julie Lisano United States
Catalina Amador United States
Mitul Gandhi United States
Arantza Onaindía
Citations per year, relative to Arantza Onaindía Arantza Onaindía (= 1×) peers Jasmin Lisfeld

Countries citing papers authored by Arantza Onaindía

Since Specialization
Citations

This map shows the geographic impact of Arantza Onaindía's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arantza Onaindía with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arantza Onaindía more than expected).

Fields of papers citing papers by Arantza Onaindía

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arantza Onaindía. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arantza Onaindía. The network helps show where Arantza Onaindía may publish in the future.

Co-authorship network of co-authors of Arantza Onaindía

This figure shows the co-authorship network connecting the top 25 collaborators of Arantza Onaindía. A scholar is included among the top collaborators of Arantza Onaindía based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arantza Onaindía. Arantza Onaindía is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hernandez, Patricia, Pablo Martínez‐Lage, Emma Camacho, et al.. (2025). Metabolic Profiling of Brain Tissue and Brain‐Derived Extracellular Vesicles in Alzheimer's Disease. Journal of Extracellular Vesicles. 14(2). e70043–e70043. 1 indexed citations
2.
Prieto‐Potín, Iván, et al.. (2025). Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype. International Journal of Molecular Sciences. 26(12). 5871–5871.
3.
Onaindía, Arantza, et al.. (2021). Molecular Update and Evolving Classification of Large B-Cell Lymphoma. Cancers. 13(13). 3352–3352. 12 indexed citations
4.
Prieto‐Torres, Lucía, Socorro Marıá Rodríguez-Pinilla, Arantza Onaindía, et al.. (2019). CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies. Haematologica. 104(2). 226–235. 29 indexed citations
5.
Mondéjar, R., Cristina Fernández, Arantza Onaindía, et al.. (2017). Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines. PLoS ONE. 12(5). e0177524–e0177524. 3 indexed citations
6.
Onaindía, Arantza, L. Jeffrey Medeiros, & Keyur P. Patel. (2017). Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms. Modern Pathology. 30(10). 1338–1366. 35 indexed citations
7.
Piris, Miguel Á., Arantza Onaindía, & Manuela Mollejo. (2016). Splenic marginal zone lymphoma. Best Practice & Research Clinical Haematology. 30(1-2). 56–64. 29 indexed citations
8.
Onaindía, Arantza, Nerea Martı́nez, Santiago Montes‐Moreno, et al.. (2015). CD30 Expression by B and T Cells. The American Journal of Surgical Pathology. 40(3). 378–385. 35 indexed citations
9.
Onaindía, Arantza, Santiago Montes‐Moreno, Socorro Marıá Rodríguez-Pinilla, et al.. (2014). Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features. Histopathology. 66(6). 846–855. 37 indexed citations
10.
Pérez, Cristina, Julia González‐Rincón, Carmen Almaráz, et al.. (2014). A Role of JAK/STAT Pathway in Cutaneous T-Cell Lymphomas: Exploring Its Effects for Targeted Therapy. Blood. 124(21). 4498–4498.
11.
Acosta, Juan Carlos, Marta Albajar, María Teresa Gómez‐Casares, et al.. (2014). High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle. Oncotarget. 5(13). 4694–4708. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026